Garland Stephens

I'll research this attorney before drafting.

Good foundation. Let me verify case outcomes and current-firm details.

Let me check a few more outcomes and firm timeline details.

Garland T. Stephens — patent litigation practice summary

Focus areas. Stephens is a Houston-based patent trial lawyer whose representative matters cluster in electrical engineering and computer technology — networking and semiconductor clients (Intel, Altera, MediaTek, ADTRAN, Nortek), storage/networking standards disputes (Alacritech, Negotiated Data Solutions, US Ethernet Innovations) — alongside a substantial life-sciences and diagnostics docket (Bio-Rad v. 10X Genomics in microfluidics, Illumina v. Natera, Guardant Health v. Foundation Medicine). He also appears in speech-recognition/NLU software litigation (Dialect, LLC v. Salesforce) and has handled trade secret matters (Cogenra Solar v. SolarCity; At Home Bondholders' Liquidating Trust). His degrees in electrical engineering (Columbia, M.S.) and mathematics (Chicago, B.S.) are consistent with that hardware/software mix, though firm and Chambers materials describe the practice generally rather than by technical niche.

Side preference — both sides. The tracked appearance data (1 plaintiff, 2 defendant) understates a genuinely mixed practice. Verifiable representative matters show him as lead or trial counsel for plaintiffs and declaratory plaintiffs (Bio-Rad, Illumina, Guardant, Nortek, ADTRAN, At Home Trustee) and for defendants (Intel as intervenor in E.D. Tex., Tesla, Altera, SolarCity). He has also filed as counsel for an NPE-side plaintiff: in Dialect, LLC v. Salesforce, Inc., No. 7:25-cv-00061 (W.D. Tex.), he filed the February 7, 2025 complaint asserting acquired VoiceBox speech-recognition patents; the case was voluntarily dismissed on September 17, 2025. He should be characterized as a both-sides trial lawyer rather than a dedicated defense or NPE specialist. Note that the three tracked appearances in the underlying data are untitled, so I could not map the plaintiff/defendant counts to specific matters.

Firm context and PTAB work. He is currently a partner at Blue Peak Law Group LLP, a Houston partner-only IP litigation boutique (Chambers USA 2026, Band 4, Intellectual Property – Texas; Best Lawyers since 2014). Before that he was a senior partner at Weil, Gotshal & Manges, managing principal of Fish & Richardson's Houston office, and a partner at Pennie & Edmonds. The structured data showing both Weil and Blue Peak is consistent with that career arc. He is a registered patent attorney and, per his firm and Chambers profiles, has served as lead counsel in numerous inter partes reviews and ex parte reexaminations; IPR work is explicitly attached to the Bio-Rad, Intel/Alacritech, and At Home Trustee matters. Bar/education: admitted in Texas, New York, and Missouri (inactive); Federal Circuit and multiple district courts; J.D., University of Missouri (1990); M.S.E.E., Columbia (1994); B.S. Mathematics, University of Chicago (1984).

Notable matters. The most thoroughly documented result is Bio-Rad Laboratories v. 10X Genomics (D. Mass.): the jury found willful infringement and awarded roughly $23.9 million at a 15% royalty, and the Federal Circuit affirmed the infringement and damages judgment and most of the permanent injunction in August 2020 (967 F.3d 1353), while vacating the injunction as to two product lines and reversing on two other patents. In Intel v. Alacritech (E.D. Tex.) and the related Federal Circuit appeal he was lead trial and lead IPR counsel for Intel as defendant/intervenor; in West View Research v. Tesla he was lead Federal Circuit counsel for appellee Tesla. Guardant Health v. Foundation Medicine, Illumina v. Natera, and Adtran v. TQ Delta appear as representative matters only — I did not verify specific outcomes for those from available sources, and none of the three tracked docket entries in the provided data carry case names, so no tracked matter can be tied to a named outcome.